Respiratory

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1136953

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1136953

Budesonide Inhaler Market, by Product Type, by Dosage, by Strength, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

PUBLISHED: September 6, 2022

PAGES: 149 Pages

DELIVERY TIME: 2-3 business days

ADD TO COMPARE

SELECT AN OPTION

Description

Budesonide is an artificial glucocorticoid steroid related to the naturally-occurring hormone, cortisol or hydrocortisone, which is produced in the adrenal glands. It is used for treating asthma. Budesonide is sold under the brand name Pulmicort. Each budesonide inhaler is designed to provide 60 to 120 inhalations depending on the device. Increasing air population is expected to lead to high prevalence of asthma worldwide. For instance, on May 11, 2022, according to the World Health Organization (WHO), Asthma is a major non-communicable disease (NCD), affecting both children and adults, and is the most common chronic disease among children globally. Asthma affected an estimated 262 million people in 2019 and caused 455 000 deaths globally. Most asthma-related deaths occur in low- and lower-middle-income countries such as India and Bangladesh, where under-diagnosis and under-treatment is a challenge.

Market Dynamics

The global demand for budesonide inhaler is expected to witness substantial growth over the forecast period, owing to increasing incidences and prevalence of asthma. According to the Global Asthma Report 2018, asthma causes around 1,000 deaths every day and affects as many as 339 million people worldwide.

Increasing product launch by the key market player in expected to boost the growth of global budesonide inhaler market over the forecast period. For instance, in November 2019, Lupin, Pharmaceutical Company, announced the launch of device to track usage pattern of metered-dose inhalers (MDI) by patients suffering from chronic respiratory diseases. The device helped the patients track their metered-dose inhalers (MDI) usage and facilitate improved adherence to therapy. The inhalers are the treatment option for managing chronic respiratory diseases such as Asthma and Chronic Obstructive Pulmonary Disease (COPD).

Key features of the study:

This report provides an in-depth analysis of the global budesonide inhaler market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2022 - 2030, considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global budesonide inhaler market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include, Pfizer Inc., Cipla Limited, Lupin Limited, Cosmo Pharmaceuticals, Takeda Pharmaceutical Company Ltd., Manus Aktteva Biopharma LLP, Abbott Laboratories, Lunan Better Pharmaceutical, Novartis International AG (Sandoz), Mylan N.V., Skyepharma, AstraZeneca Plc., Chiesi Farmaceutici S.p.A, Orion Corporation, Santarus Inc., Synmosa Biopharma Corporation, and Shanghai Sine Pharmaceutical Laboratories Co. Ltd.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global budesonide inhaler market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, suppliers, research and consulting firms, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global budesonide inhaler market.

Detailed Segmentation:

Global Budesonide Inhaler Market, By Product type:
- Inhalants
- Nebulizer
Global Budesonide Inhaler Market, By Dosage:
- Aerosols
- Dry Powder
- Suspension
- Spray
Global Budesonide Inhaler Market, By Strength:
- 25 mg
- 5 mg
- 0 mg
Global Budesonide Inhaler Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Budesonide Inhaler Market, By Region:
- North America
  - By Country
- U.S.
- Canada
- Europe
  - By Country
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- Latin America
  - By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
  - By Country
- GCC
- Israel
- Rest of Middle East
- Africa
  - Others By Country/Region
- South Africa
- Central Africa
- North Africa
Company Profiles
- Pfizer Inc.*
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Cipla Limited
- Lupin Limited
- Cosmo Pharmaceuticals
- Takeda Pharmaceutical Company Ltd.
- Manus Aktteva Biopharma LLP
- Abbott Laboratories
- Lunan Better Pharmaceutical
- Novartis International AG (Sandoz)
- Mylan N.V.
- Skyepharma,
- AstraZeneca Plc.
- Chiesi Farmaceutici S.p.A.
- Orion Corporation
- Santarus Inc.
- Synmosa Biopharma Corporation
- Shanghai Sine Pharmaceutical Laboratories Co. Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI2551

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Dosage
- Market Snapshot, By Strength
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Landscape
Product Recall
Epidemiology Analysis
Technology Overview
PEST Analysis
Porter's Five Forces Model

4. Global Budesonide Inhaler Market - Impact of Coronavirus (Covid-19) Pandemic

Overall Impact
COVID-19 Impact on the market

5. Global Budesonide Inhaler Market, By Product Type, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Inhalants
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Nebulizers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Budesonide Inhaler Market, By Dosage,2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017- 2030
- Segment Trends
Aerosols
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Dry Powder
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Suspension
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Spray
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Budesonide Inhaler Market, By Strength,2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017- 2030
- Segment Trends
25mg
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
5mg
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
0mg
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Budesonide Inhaler Market, By Distribution Channel, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million )

9. Global Budesonide Inhaler Market,, By Region, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Strength, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million )
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Strength, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million )
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Strength, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million )
UK
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Strength, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million )
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Strength, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million )
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Strength, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million )
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million )
North Africa
Central Africa
South Africa

10. Competitive Landscape

Heat Map Analysis
Company Profile
- Pfizer, Inc.
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Cipla Limited
- Lupin Limited
- Cosmo Pharmaceuticals
- Takeda Pharmaceutical Company Ltd
- Manus Aktteva Biopharma LLP
- Abbott Laboratories
- Lunan Better Pharmaceutical
- Novartis International AG (Sandoz)
- Mylan N.V.
- Skyepharma
- AstraZeneca Plc.
- Chiesi Farmaceutici S.p.A.
- Orion Corporation
- Santarus Inc.
- Synmosa Biopharma Corporation
- Shanghai Sine Pharmaceutical Laboratories Co. Ltd.
Analyst Views

11. Section

References
Research Methodology
About Us

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ